Krystal Biotech, Inc. EPS (Earnings per Share) 2016–2025
Krystal Biotech, Inc. reported $6.84 of earnings per share for fiscal 2025. That was 128.0% higher than fiscal 2024. Compared with fiscal 2020, the change was +500.0%.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $6.84 | +128.0% |
| FY 2024 | $3.00 | +669.2% |
| FY 2023 | $0.39 | +107.1% |
| FY 2022 | $-5.49 | -75.4% |
| FY 2021 | $-3.13 | -83.0% |
| FY 2020 | $-1.71 | — |
| FY 2019 | $0.00 | — |
| FY 2018 | $0.00 | — |
| FY 2017 | $0.00 | — |
| FY 2016 | $0.00 | — |
Source: Krystal Biotech, Inc. SEC filings — income statement (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open KRYS 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Krystal Biotech, Inc. reported $6.84 of earnings per share for fiscal 2025. That was 128.0% higher than fiscal 2024. Compared with fiscal 2020, the change was +500.0%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Krystal Biotech, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeKrystal Biotech, Inc. — frequently asked questions
What is Krystal Biotech, Inc.'s earnings per share?
Krystal Biotech, Inc. (KRYS) reported earnings per share of $6.84 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Krystal Biotech, Inc.'s official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.